» Articles » PMID: 33965736

The Child Behavior Checklist Can Aid in Characterizing Suspected Comorbid Psychopathology in Clinically Referred Youth with ADHD

Overview
Journal J Psychiatr Res
Specialty Psychiatry
Date 2021 May 9
PMID 33965736
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the utility of the Child Behavior Checklist (CBCL) to aid in the identification of comorbid psychopathological conditions affecting referred youth with suspected ADHD prior to the evaluation. The CBCL is an easy-to-use assessment tool that may provide invaluable information regarding the severity and characteristics of the presenting complaints.

Methods: The sample included 332 youths consecutively referred to an ADHD program for the assessment of suspected ADHD. Parents completed the CBCL, parent-rated ADHD Self-Report Scale (ASRS), Social Responsiveness Scale (SRS), and Behavior Rating Inventory of Executive Function (BRIEF). Because of the established association between the CBCL Attention Problems scale and a structured diagnostic interview of ADHD, all youths analyzed had abnormal Attention Problems T-scores (≥60).

Results: Seventy-six percent of youths with elevated Attention Problems T-scores had ≥3 additional abnormal CBCL scales, suggesting they were likely affected with multiple comorbid psychopathological conditions. Moreover, 44% had ≥1 CBCL clinical scale with a T-score more severe than their Attention Problems T-score, suggesting the putative comorbid condition was more severe than the ADHD symptoms. Additional CBCL scale elevations were associated with more severe functional impairments as assessed by the ASRS, SRS, BRIEF, and CBCL competence scales.

Conclusion: The CBCL obtained before the clinical assessment identified high rates of comorbid psychopathology in youths referred for the assessment of ADHD. It provided detailed information about the types and severity of suspected psychopathological conditions impacting a particular youth, which is critical to guide the assessing clinician on likely differing needs of the affected child.

Citing Articles

Exploring the potential association between stimulant or atomoxetine use and suicidal or self-injurious behaviors in children with attention deficit hyperactivity disorder: real-world insights from the FAERS database.

Liu J, Xue L, Zeng F, Liu Y, Zhu Y, Zhou J Eur Child Adolesc Psychiatry. 2025; .

PMID: 40047929 DOI: 10.1007/s00787-025-02694-w.


Characterizing executive functioning and associated behaviors in individuals with dual-specificity tyrosine phosphorylation-regulated kinase 1A () syndrome.

Rea H, Webb S, Kurtz-Nelson E, Hudac C, Bernier R, Miles C Front Neurosci. 2025; 18():1485499.

PMID: 39840013 PMC: 11747226. DOI: 10.3389/fnins.2024.1485499.


Functional Gastrointestinal Symptoms in Children with Autism and ADHD: Profiles of Hair and Salivary Cortisol, Serum Leptin Concentrations and Externalizing/Internalizing Problems.

Petropoulos A, Anesiadou S, Michou M, Lymperatou A, Roma E, Chrousos G Nutrients. 2024; 16(10).

PMID: 38794776 PMC: 11124526. DOI: 10.3390/nu16101538.


Behavioural and neuropsychological outcomes in children exposed in utero to maternal labour epidural analgesia.

Isik O, Junaid S, Guo L, Lackraj D, Landau R, Miles C Br J Anaesth. 2024; 133(2):334-343.

PMID: 38702238 PMC: 11590713. DOI: 10.1016/j.bja.2024.02.036.


Adult attention deficit hyperactivity disorder: a comprehensive review.

Williams O, Prasad S, McCrary A, Jordan E, Sachdeva V, Deva S Ann Med Surg (Lond). 2023; 85(5):1802-1810.

PMID: 37228994 PMC: 10205222. DOI: 10.1097/MS9.0000000000000631.


References
1.
Visser S, Danielson M, Bitsko R, Holbrook J, Kogan M, Ghandour R . Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry. 2013; 53(1):34-46.e2. PMC: 4473855. DOI: 10.1016/j.jaac.2013.09.001. View

2.
Biederman J, Ball S, Monuteaux M, Kaiser R, Faraone S . CBCL clinical scales discriminate ADHD youth with structured-interview derived diagnosis of oppositional defiant disorder (ODD). J Atten Disord. 2007; 12(1):76-82. DOI: 10.1177/1087054707299404. View

3.
Volk H, Henderson C, Neuman R, Todd R . Validation of population-based ADHD subtypes and identification of three clinically impaired subtypes. Am J Med Genet B Neuropsychiatr Genet. 2006; 141B(3):312-8. DOI: 10.1002/ajmg.b.30299. View

4.
MACDONALD V, Achenbach T . Attention problems versus conduct problems as six-year predictors of problem scores in a national sample. J Am Acad Child Adolesc Psychiatry. 1996; 35(9):1237-46. DOI: 10.1097/00004583-199609000-00021. View

5.
Biederman J, Monuteaux M, Kendrick E, Klein K, Faraone S . The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD. Arch Dis Child. 2005; 90(10):1010-5. PMC: 1720123. DOI: 10.1136/adc.2004.056937. View